{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:08:38Z","timestamp":1790161718801,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12757-z","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:11:31Z","timestamp":1790158291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the METTL5\u2013MGST1 axis for cancer therapy: molecular mechanisms and therapeutic implications"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9351-9803","authenticated-orcid":false,"given":"Abinash","family":"Nayak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0517-3103","authenticated-orcid":false,"given":"Sudhansu Sekhar","family":"Nishank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"12757_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2022) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"12757_CR2","doi-asserted-by":"crossref","unstructured":"Barbieri I, Cancer TK-NR (2020) undefined. Role of RNA modifications in cancer. NatureComI Barbieri, T KouzaridesNature Reviews Cancer, 2020\u2022natureCom n.d.","DOI":"10.1038\/s41568-020-0253-2"},{"issue":"1","key":"12757_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01477-7","volume":"16","author":"YN Qi","year":"2023","unstructured":"Qi YN, Liu Z, Hong LL, Li P, Ling ZQ (2023) Methyltransferase-like proteins in cancer biology and potential therapeutic targeting. J Hematol Oncol 16(1):89. https:\/\/doi.org\/10.1186\/s13045-023-01477-7","journal-title":"J Hematol Oncol"},{"key":"12757_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1522157","volume":"15","author":"Y Yan","year":"2025","unstructured":"Yan Y, Fu J (2025) The human 18S rRNA m6A methyltransferase METTL5 promotes tumorigenesis via DEPDC1 in lung squamous cell carcinoma. Front Oncol 15:1522157. https:\/\/doi.org\/10.3389\/fonc.2025.1522157","journal-title":"Front Oncol"},{"key":"12757_CR5","doi-asserted-by":"publisher","unstructured":"Zhang J, Ye Z wei, Morgenstern R, Townsend DM, Tew KD (2023) Microsomal glutathione transferase 1 in cancer and the regulation of ferroptosis. Adv Cancer Res 160:107\u201332. https:\/\/doi.org\/10.1016\/bs.acr.2023.05.001.","DOI":"10.1016\/bs.acr.2023.05.001"},{"key":"12757_CR6","doi-asserted-by":"publisher","unstructured":"Ji T, Miao X, Fang Y, Nie J, Zhu Q, Zhu P, et al (2026)METTL5 promotes tumor progression and ferroptosis resistance via MGST1 in HCC. SpringerT Ji, X Miao, Y Fang, J Nie, Q Zhu, P Zhu, W Liao, D Yang, D YangMolecular and Cellular Biochemistry.\u2022Springer 2026. https:\/\/doi.org\/10.1007\/s11010-025-05475-w.","DOI":"10.1007\/s11010-025-05475-w"},{"key":"12757_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1663423","author":"X Chen","year":"2025","unstructured":"Chen X, Liu X, Xu J, Zhu X, Liu B, Yang X et al (2025) The inspiration of methyltransferase in RNA methylation modification for targeted therapy of malignant tumors. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2025.1663423","journal-title":"Front Immunol"},{"key":"12757_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1708541","volume":"13","author":"C Li","year":"2025","unstructured":"Li C, Jiang X, Yuan Y, Wang Q (2025) METTL5 in physiology and pathology: mechanisms and implications. Front Cell Dev Biol 13:1708541. https:\/\/doi.org\/10.3389\/fcell.2025.1708541","journal-title":"Front Cell Dev Biol"},{"key":"12757_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/nph.20034","volume":"244","author":"P Song","year":"2024","unstructured":"Song P, Tian E, Cai Z, Chen X, Chen S, Yu K et al (2024) Methyltransferase ATMETTL5 writes m6A on 18S ribosomal RNA to regulate translation in Arabidopsis. New Phytol 244:571\u201387. https:\/\/doi.org\/10.1111\/nph.20034","journal-title":"New Phytol"},{"issue":"10","key":"12757_CR10","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/s12276-022-00869-y","volume":"54","author":"EM Turkalj","year":"2022","unstructured":"Turkalj EM, Vissers C (2022) The emerging importance of METTL5-mediated ribosomal RNA methylation. Exp Mol Med 54(10):1617\u201325. https:\/\/doi.org\/10.1038\/s12276-022-00869-y","journal-title":"Exp Mol Med"},{"key":"12757_CR11","doi-asserted-by":"crossref","unstructured":"Sepich-Poore C, Zheng Z, Schmitt E, KW-J of B (2022) undefined. The METTL5-TRMT112 N6-methyladenosine methyltransferase complex regulates mRNA translation via 18S rRNA methylation. ElsevierC Sepich-Poore, Z Zheng, E Schmitt, K Wen, ZS Zhang, XL Cui, Q Dai, AC Zhu, L ZhangJournal of Biological Chemistry, 2022\u2022Elsevier n.d.","DOI":"10.1016\/j.jbc.2022.101590"},{"key":"12757_CR12","doi-asserted-by":"crossref","unstructured":"Dai Z, Zhu W, Hou Y, Zhang X, Ren X, Lei K, et al (2023) METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression. CellComZ Dai, W Zhu, Y Hou, X Zhang, X Ren, K Lei, J Liao, H Liu, Z Chen, S Peng, S Li, S LinMolecular Therapy.\u2022cellCom n.d.","DOI":"10.1016\/j.ymthe.2023.09.014"},{"issue":"1","key":"12757_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12015-022-10444-7","volume":"19","author":"JG Tooley","year":"2022","unstructured":"Tooley JG, Catlin JP, Tooley CES (2022) METTLing in stem cell and cancer biology. Stem Cell Rev Rep 19(1):76\u201391. https:\/\/doi.org\/10.1007\/s12015-022-10444-7","journal-title":"Stem Cell Rev Rep"},{"key":"12757_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/HMG","volume":"35","author":"H Owens","year":"2026","unstructured":"Owens H, Gamble GD, Bjornholdt MC, Boyce NK, Keung L (2026) Heterozygous loss-of-function variant in METTL5 is associated with intellectual disability. Hum Mol Genet 35:312\u20138. https:\/\/doi.org\/10.1093\/HMG","journal-title":"Hum Mol Genet"},{"issue":"1","key":"12757_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11033-024-10207-2","volume":"52","author":"S Heydari","year":"2025","unstructured":"Heydari S, Peymani M, Hashemi M, Ghaedi K, Entezari M (2025) Potential prognostic and predictive biomarkers: METTL5, METTL7A, and METTL7B expression in gastrointestinal cancers. Mol Biol Rep 52(1):151. https:\/\/doi.org\/10.1007\/s11033-024-10207-2","journal-title":"Mol Biol Rep"},{"key":"12757_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7165","author":"Q Wang","year":"2024","unstructured":"Wang Q, Huang Y, Zhu Y, Zhang W, Wang B, Du X et al (2024) The m6A methyltransferase METTL5 promotes neutrophil extracellular trap network release to regulate hepatocellular carcinoma progression. Cancer Med. https:\/\/doi.org\/10.1002\/cam4.7165","journal-title":"Cancer Med"},{"key":"12757_CR17","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2021.5299","author":"H Huang","year":"2022","unstructured":"Huang H, Li H, Pan R, Wang S, Khan AA, Zhao Y et al (2022) Ribosome 18S m6A methyltransferase METTL5 promotes pancreatic cancer progression by modulating c-Myc translation. Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2021.5299","journal-title":"Int J Oncol"},{"key":"12757_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108544","author":"B Rong","year":"2020","unstructured":"Rong B, Zhang Q, Wan J, Xing S, Dai R, Li Y et al (2020) Ribosome 18S m6A methyltransferase METTL5 promotes translation initiation and breast cancer cell growth. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2020.108544","journal-title":"Cell Rep"},{"issue":"1","key":"12757_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02166-1","volume":"10","author":"X Li","year":"2024","unstructured":"Li X, Yang G, Ma L, Tang B, Tao T (2024) N6-methyladenosine (m6A) writer METTL5 represses the ferroptosis and antitumor immunity of gastric cancer. Cell Death Discov 10(1):402. https:\/\/doi.org\/10.1038\/s41420-024-02166-1","journal-title":"Cell Death Discov"},{"key":"12757_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202507718","author":"J Hou","year":"2025","unstructured":"Hou J, Ju CW, Egan NA, Wei Y, Wang Y, Dang M et al (2025) Tumor intrinsic METTL5 modulates ATF4 translation to prevent T cell\u2010induced ferroptosis in ovarian cancer. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202507718","journal-title":"Adv Sci"},{"key":"12757_CR21","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1080\/21655979.2022.2036912","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Ma H, Ma L, Li K, Kang Y (2022) The potential role of methyltransferase-like 5 in deficient mismatch repair of uterine corpus endometrial carcinoma. Bioengineered 13:5525. https:\/\/doi.org\/10.1080\/21655979.2022.2036912","journal-title":"Bioengineered"},{"issue":"1","key":"12757_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37807-5","volume":"13","author":"L Wang","year":"2023","unstructured":"Wang L, Peng Jlin (2023) METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment. Sci Rep 13(1):10755-. https:\/\/doi.org\/10.1038\/s41598-023-37807-5","journal-title":"Sci Rep"},{"issue":"1","key":"12757_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-025-11377-4","volume":"26","author":"S Wang","year":"2025","unstructured":"Wang S, Xu Z, Wang Z, Yi X, Wu J (2025) M6A methyltransferase METTL3 promotes glucose metabolism hub gene expression and induces metabolic dysfunction-associated steatotic liver disease (MASLD). BMC Genomics 26(1):188-. https:\/\/doi.org\/10.1186\/s12864-025-11377-4","journal-title":"BMC Genomics"},{"key":"12757_CR24","unstructured":"Peng H, Chen B, Wei W, Guo S, Han H, CY-N, et al. N6-methyladenosine (m6A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation. NatureCom n.d."},{"key":"12757_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/lci2.68","volume":"4","author":"J Liu","year":"2023","unstructured":"Liu J, Waugh MG (2023) The regulation and functions of ACSL3 and ACSL4 in the liver and hepatocellular carcinoma. Liver Cancer Int 4:28\u201341. https:\/\/doi.org\/10.1002\/lci2.68","journal-title":"Liver Cancer Int"},{"key":"12757_CR26","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.20892\/j.issn.2095-3941.2024.0415","volume":"21","author":"Y Cheng","year":"2024","unstructured":"Cheng Y, Shang Y, Zhang S, Fan S (2024) The interplay between RNA m6A modification and radiation biology of cancerous and non-cancerous tissues: a narrative review. Cancer Biol Med 21:1120\u201340. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2024.0415","journal-title":"Cancer Biol Med"},{"key":"12757_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/1120009X.2022.2143614","volume":"35","author":"W Xu","year":"2023","unstructured":"Xu W, Liu S, Zhang G, Liu J, Cao G (2023) Knockdown of METTL5 inhibits the Myc pathway to downregulate PD-L1 expression and inhibits immune escape of hepatocellular carcinoma cells. J Chemother 35:455\u201364. https:\/\/doi.org\/10.1080\/1120009X.2022.2143614","journal-title":"J Chemother"},{"key":"12757_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202512528","author":"S Li","year":"2026","unstructured":"Li S, Zhao X, Song T, Chen Q, Wu Y, Zhang Y et al (2026) METTL5 enables immune evasion of liver cancer via chemokine mRNA translation regulation. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202512528","journal-title":"Adv Sci"},{"key":"12757_CR29","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/JJCO","volume":"49","author":"K Tanaka","year":"2026","unstructured":"Tanaka K, Tamakoshi A, Sugawara Y, Mizoue T, Inoue M, Sawada N et al (2026) RNA modifications in cancer and their detection: a review. Jpn J Clin Oncol 49:972\u201384. https:\/\/doi.org\/10.1093\/JJCO","journal-title":"Jpn J Clin Oncol"},{"key":"12757_CR30","doi-asserted-by":"publisher","first-page":"23683","DOI":"10.1021\/acsomega.3c01782","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Xu X, Wang X, Zhang C, Hu A, Li Y (2023) MGST1 expression is associated with poor prognosis, enhancing the Wnt\/\u03b2-catenin pathway via regulating AKT and inhibiting ferroptosis in gastric cancer. ACS Omega 8:23683\u201394. https:\/\/doi.org\/10.1021\/acsomega.3c01782","journal-title":"ACS Omega"},{"key":"12757_CR31","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.2174\/0115680096317925240820053934","volume":"25","author":"Y Ma","year":"2024","unstructured":"Ma Y, Peng Y, Cheng S, Jin L (2024) Targeting MGST1 makes non-small cell lung cancer cells sensitive to radiotherapy by epigenetically enhancing ALOX15-mediated ferroptosis. Curr Cancer Drug Targets 25:1271\u201384. https:\/\/doi.org\/10.2174\/0115680096317925240820053934","journal-title":"Curr Cancer Drug Targets"},{"key":"12757_CR32","doi-asserted-by":"publisher","DOI":"10.1177\/09603271231172915","author":"Z Peng","year":"2023","unstructured":"Peng Z (2023) Microsomal glutathione S-transferase 1 targets the autophagy signaling pathway to suppress ferroptosis in gastric carcinoma cells. Hum Exp Toxicol. https:\/\/doi.org\/10.1177\/09603271231172915","journal-title":"Hum Exp Toxicol"},{"key":"12757_CR33","doi-asserted-by":"crossref","unstructured":"Zhang J, Ye Z, Chakraborty P, ZL-P (2023) undefined. Microsomal glutathione transferase 1 controls metastasis and therapeutic response in melanoma. ElsevierJ Zhang, Z Ye, P Chakraborty, Z Luo, J Culpepper, M Aslam, L Zhang, K JohanssonPharmacological Research, 2023\u2022Elsevier n.d.","DOI":"10.1016\/j.phrs.2023.106899"},{"key":"12757_CR34","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.chembiol.2021.01.006","volume":"28","author":"F Kuang","year":"2021","unstructured":"Kuang F, Liu J, Xie Y, Tang D, Kang R (2021) MGST1 is a redox-sensitive repressor of ferroptosis in pancreatic cancer cells. Cell Chem Biol 28:765-775.e5. https:\/\/doi.org\/10.1016\/j.chembiol.2021.01.006","journal-title":"Cell Chem Biol"},{"key":"12757_CR35","doi-asserted-by":"publisher","unstructured":"Yan T, Hu P, Lv S, Ye M, Wu M, HF-CC and, et al (2024) ZNF384 transcriptionally activated MGST1 to confer TMZ resistance of glioma cells by negatively regulating ferroptosis. SpringerT Yan, P Hu, S Lv, M Ye, M Wu, H Fang, B XiaoCancer Chemotherapy and Pharmacology. Springer n.d. https:\/\/doi.org\/10.1007\/S00280-024-04654-4.","DOI":"10.1007\/S00280-024-04654-4"},{"key":"12757_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109562","author":"B Zeng","year":"2020","unstructured":"Zeng B, Ge C, Li R, Zhang Z, Fu Q, Li Z et al (2020) Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2019.109562","journal-title":"Biomed Pharmacother"},{"key":"12757_CR37","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.1016\/j.ymthe.2025.08.009","volume":"33","author":"M Zhang","year":"2025","unstructured":"Zhang M, Zhang X, Tan C, Jiang T, Cao Z, Chen Y et al (2025) METTL5 deficiency induces oligoasthenoteratozoospermia via impaired 18S rRNA m6A methylation in humans and mice. Mol Ther 33:5883\u2013900. https:\/\/doi.org\/10.1016\/j.ymthe.2025.08.009","journal-title":"Mol Ther"},{"key":"12757_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/jop.13601","volume":"54","author":"R Huang","year":"2025","unstructured":"Huang R, Feng X, Zhou T, Lu J, Wang Y, Zhang S et al (2025) METTL5 promotes tumor progression in oral squamous cell carcinoma by activating the Myc pathway. J Oral Pathol Med 54:91\u20139. https:\/\/doi.org\/10.1111\/jop.13601","journal-title":"J Oral Pathol Med"},{"issue":"4","key":"12757_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s10735-025-10495-3","volume":"56","author":"N Chen","year":"2025","unstructured":"Chen N, Zhang Z, Shen F, Lu D (2025) METTL5-mediated m6A modification of UBE3C promotes osteosarcoma progression by suppressing ferroptosis via inducing AHNAK ubiquitination. J Mol Histol 56(4):235. https:\/\/doi.org\/10.1007\/s10735-025-10495-3","journal-title":"J Mol Histol"},{"key":"12757_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/S11427-024-2938-3","author":"Z Yuan","year":"2025","unstructured":"Yuan Z, Liu T, Jiang P, Zhao Y, Guo R, Ye X et al (2025) PEX5 deficiency enhances radiosensitivity via MGST1-GSH detoxifying function and promotes ferroptosis in liver cancer. Science China Life Sci. https:\/\/doi.org\/10.1007\/S11427-024-2938-3","journal-title":"Science China Life Sci"},{"key":"12757_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/S41419-026-08796-W","author":"P Tabnak","year":"2026","unstructured":"Tabnak P, Ebrahimnezhad M, HajiEsmailPoor Z (2026) Genetic mutations governing ferroptosis sensitivity and resistance: a precision approach to cancer therapy. Cell Death Dis. https:\/\/doi.org\/10.1038\/S41419-026-08796-W","journal-title":"Cell Death Dis"},{"key":"12757_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.111740","volume":"131","author":"H Zheng","year":"2025","unstructured":"Zheng H, Dong Y, Zhang X, Liu J, Geng X, Liu Z et al (2025) Modulation of Mettl5 alleviates airway allergy by regulating the epigenetic profile of M2 macrophages. Cell Signal 131:111740. https:\/\/doi.org\/10.1016\/j.cellsig.2025.111740","journal-title":"Cell Signal"},{"key":"12757_CR43","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.109982.1","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Shi X, Wang Y, Wang R, Lin F, Cao Y et al (2026) Depletion of rRNA Methyltranferase METTL5 enhances anti-tumor immune response via neoantigen generated from cryptic translation. Elife. https:\/\/doi.org\/10.7554\/eLife.109982.1","journal-title":"Elife"},{"key":"12757_CR44","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1021\/acs.jmedchem.4c02225","volume":"68","author":"G Dutheuil","year":"2025","unstructured":"Dutheuil G, Oukoloff K, Korac J, Lenoir F, El Bousmaqui M, Probst N et al (2025) Discovery, optimization, and preclinical pharmacology of EP652, a METTL3 inhibitor with efficacy in liquid and solid tumor models. J Med Chem 68:2981\u20133003. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c02225","journal-title":"J Med Chem"},{"key":"12757_CR45","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1016\/S0959-8049(22)01128-5","volume":"174","author":"Y Ofir-Rosenfeld","year":"2022","unstructured":"Ofir-Rosenfeld Y, Vasiliauskait\u0117 L, Saunders C, Sapetschnig A, Tsagkogeorga G, Albertella M et al (2022) STC-15, an oral small molecule inhibitor of the RNA methyltransferase METTL3, inhibits tumour growth through activation of anti-cancer immune responses associated with increased interferon signalling, and synergises with T cell checkpoint blockade. Eur J Cancer 174:S123. https:\/\/doi.org\/10.1016\/S0959-8049(22)01128-5","journal-title":"Eur J Cancer"},{"issue":"1","key":"12757_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-025-00788-5","volume":"203","author":"C He","year":"2025","unstructured":"He C, Ji Y, Zhang Y, Ou J, Wu D, Qin H et al (2025) Inhibition of Mettl3 by STM2457 and loss of macrophage Mettl3 alleviate pulmonary hypertension and right heart remodeling. Lung 203(1):34. https:\/\/doi.org\/10.1007\/s00408-025-00788-5","journal-title":"Lung"},{"key":"12757_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104955","author":"S Radbakhsh","year":"2025","unstructured":"Radbakhsh S, Najar M, Merimi M, Benderdour M, Fernandes JC, Martel-Pelletier J et al (2025) RNA modifications in osteoarthritis: epitranscriptomic insights into pathogenesis and therapeutic targets. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26104955","journal-title":"Int J Mol Sci"},{"issue":"1","key":"12757_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35978-9","volume":"13","author":"JW Kim","year":"2023","unstructured":"Kim JW, Min DW, Kim D, Kim J, Kim MJ, Lim H et al (2023) GPX4 overexpressed non-small cell lung cancer cells are sensitive to RSL3-induced ferroptosis. Sci Rep 13(1):8872. https:\/\/doi.org\/10.1038\/s41598-023-35978-9","journal-title":"Sci Rep"},{"issue":"12","key":"12757_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06241-w","volume":"14","author":"B Chen","year":"2023","unstructured":"Chen B, Hong Y, Zhai X, Deng Y, Hu H, Tian S et al (2023) m6A and m5C modification of GPX4 facilitates anticancer immunity via STING activation. Cell Death Dis 14(12):809. https:\/\/doi.org\/10.1038\/s41419-023-06241-w","journal-title":"Cell Death Dis"},{"key":"12757_CR50","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.2604695123","volume":"123","author":"G Li","year":"2026","unstructured":"Li G, Li Q, Zhang J, Huang Y, Tao W, Cheng Y et al (2026) P53 overrides METTL5 loss\u2013induced tumor suppression via mitochondrial respiration. Proc Natl Acad Sci U S A 123:e2604695123. https:\/\/doi.org\/10.1073\/PNAS.2604695123","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12757-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12757-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12757-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:11:35Z","timestamp":1790158295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12757-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12757"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12757-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"20 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable for review article.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable for review article.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable for review article.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1612"}}